Serum from patients with severe COVID-19 significantly upregulated genes involved in the cellular antioxidant response in HUVEC, including NFE2L2, HMOX1, SOD1, CAT, GPX1, and GSR. This evidence concerns the gene NFE2L2 and COVID-19.